One striking finding was that serum of both pediatric and adult SMA patients displayed increased levels of IFN-γ, IL-17a and IL-22, which are signature cytokines of activated Th1/Th17cells (Damsker et al., 2010). This evidence concerns the gene IL17A and proximal spinal muscular atrophy.